|
Condensed Statements of Operations (Unaudited) (USD $)
|
3 Months Ended |
6 Months Ended |
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
| Revenues: |
|
|
|
|
| Related party license revenues |
$ 650,000 |
$ 650,000 |
$ 1,300,000 |
$ 1,300,000 |
| Service revenues |
142,404 |
|
250,734 |
|
| Product revenues |
291,356 |
72,887 |
513,025 |
199,081 |
| Total revenues |
1,083,760 |
722,887 |
2,063,759 |
1,499,081 |
| Costs and operating expenses: |
|
|
|
|
| Cost of product revenues |
156,757 |
30,397 |
258,426 |
113,337 |
| Research and development : |
|
|
|
|
| Research and development costs |
486,022 |
1,058,618 |
1,175,691 |
2,223,725 |
| Reversal of R&D obligation (see Note 9) |
(882,537) |
|
(882,537) |
|
| Selling, general, and administrative |
1,803,045 |
1,105,921 |
3,143,148 |
2,341,476 |
| Total costs and operating expenses |
1,563,287 |
2,194,936 |
3,694,728 |
4,678,538 |
| Operating loss |
(479,527) |
(1,472,049) |
(1,630,969) |
(3,179,457) |
| Other income (expense): |
|
|
|
|
| Other expense, net |
(25,795) |
(491) |
(24,625) |
(2,911) |
| Interest income |
1,361 |
1,708 |
2,980 |
2,793 |
| Interest expense (see Note 8) |
(96,018) |
(598,450) |
(2,421,754) |
(1,140,325) |
| Net loss |
$ (599,979) |
$ (2,069,282) |
$ (4,074,368) |
$ (4,319,900) |
| Net loss per share attributable to common stockholders: |
|
|
|
|
| Basic and diluted (in Dollars per share) |
$ (0.01) |
$ (0.13) |
$ (0.12) |
$ (0.27) |
| Weighted average shares outstanding: |
|
|
|
|
| Basic and diluted (in Shares) |
40,596,069 |
15,859,990 |
32,891,808 |
15,859,990 |